Merck Leaps Into COVID-19 Development Fray With Vaccine, Drug Deals Merck Leaps Into COVID-19 Development Fray With Vaccine, Drug Deals
Merck, which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
More News: AIDS Vaccine | Austria Health | COVID-19 | Infectious Diseases | Intensive Care | Merck | Vaccines